Drug intelligence / Profile preview

3-oxo-4-androstene-17beta-carboxylic acid

Development stage
Unknown
Lead developer
Jiangsu Jiaerke Pharmaceuticals
Modality
Small Molecules
Administration
Topical, Oral, Rectal, Parenteral, Ophthalmic, Otic
01

Overview

3-oxo-4-androstene-17beta-carboxylic acid is a steroidal small molecule and active pharmaceutical ingredient (API) intermediate produced by Jiangsu Jiaerke Pharmaceuticals. It serves as a critical structural precursor in the industrial synthesis of various steroid-based medications. Most notably, it is a key intermediate in the production of 5-alpha reductase inhibitors such as finasteride and dutasteride, which are used to treat benign prostatic hyperplasia (BPH) and androgenetic alopecia. As an intermediate, its primary role is as a chemical building block in pharmaceutical manufacturing rather than as a finished therapeutic agent. It is typically supplied as a bulk API for further chemical transformation into final drug products.

Other names
Androst-4-en-3-one-17beta-carboxylic acidAndrost4-en-3-one-17beta-carboxylic acidAndrost 4-en-3-one-17beta-carboxylic acidDelta4-etienic acidDelta-4-etienic acidDelta 4-etienic acid4-Etienic acid-3-one3-Oxoandrost-4-ene-17beta-carboxylic acidEtienic acid3-Oxo-4-etienic acid4-Androsten-3-one-17beta-carboxylic acid

Beyond the preview

Go deeper on 3-oxo-4-androstene-17beta-carboxylic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-oxo-4-androstene-17beta-carboxylic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call